200 related articles for article (PubMed ID: 19508172)
1. Targeting the mevalonate pathway for improved anticancer therapy.
Fritz G
Curr Cancer Drug Targets; 2009 Aug; 9(5):626-38. PubMed ID: 19508172
[TBL] [Abstract][Full Text] [Related]
2. Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.
Sarrabayrouse G; Pich C; Teiti I; Tilkin-Mariame AF
Int J Cancer; 2017 Feb; 140(4):747-755. PubMed ID: 27616679
[TBL] [Abstract][Full Text] [Related]
3. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics.
Walker K; Olson MF
Curr Opin Genet Dev; 2005 Feb; 15(1):62-8. PubMed ID: 15661535
[TBL] [Abstract][Full Text] [Related]
4. Novel aspects of mevalonate pathway inhibitors as antitumor agents.
Thurnher M; Nussbaumer O; Gruenbacher G
Clin Cancer Res; 2012 Jul; 18(13):3524-31. PubMed ID: 22529099
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
Fritz G
Int J Oncol; 2005 Nov; 27(5):1401-9. PubMed ID: 16211237
[TBL] [Abstract][Full Text] [Related]
6. Mevalonate-suppressive dietary isoprenoids for bone health.
Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
[TBL] [Abstract][Full Text] [Related]
7. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer therapy: targeting the mevalonate pathway.
Swanson KM; Hohl RJ
Curr Cancer Drug Targets; 2006 Feb; 6(1):15-37. PubMed ID: 16475974
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of statins: A focus on cancer.
Ahmadi M; Amiri S; Pecic S; Machaj F; Rosik J; Łos MJ; Alizadeh J; Mahdian R; da Silva Rosa SC; Schaafsma D; Shojaei S; Madrakian T; Zeki AA; Ghavami S
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165968. PubMed ID: 32927022
[TBL] [Abstract][Full Text] [Related]
11. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
[TBL] [Abstract][Full Text] [Related]
12. Rho GTPases: promising cellular targets for novel anticancer drugs.
Fritz G; Kaina B
Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
[TBL] [Abstract][Full Text] [Related]
13. [The role of mevalonate pathway in osteogenic cells].
Ishimi Y
Nihon Rinsho; 2004 Feb; 62 Suppl 2():779-82. PubMed ID: 15035226
[No Abstract] [Full Text] [Related]
14. Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.
Alizadeh J; Zeki AA; Mirzaei N; Tewary S; Rezaei Moghadam A; Glogowska A; Nagakannan P; Eftekharpour E; Wiechec E; Gordon JW; Xu FY; Field JT; Yoneda KY; Kenyon NJ; Hashemi M; Hatch GM; Hombach-Klonisch S; Klonisch T; Ghavami S
Sci Rep; 2017 Mar; 7():44841. PubMed ID: 28344327
[TBL] [Abstract][Full Text] [Related]
15. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
Göbel A; Thiele S; Browne AJ; Rauner M; Zinna VM; Hofbauer LC; Rachner TD
Cancer Lett; 2016 May; 375(1):162-171. PubMed ID: 26968247
[TBL] [Abstract][Full Text] [Related]
17. Using inhibitors of prenylation to block localization and transforming activity.
Berzat AC; Brady DC; Fiordalisi JJ; Cox AD
Methods Enzymol; 2006; 407():575-97. PubMed ID: 16757354
[TBL] [Abstract][Full Text] [Related]
18. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.
Karlic H; Thaler R; Gerner C; Grunt T; Proestling K; Haider F; Varga F
Cancer Genet; 2015 May; 208(5):241-52. PubMed ID: 25978957
[TBL] [Abstract][Full Text] [Related]
20. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application.
Jiao X; Ashtari N; Rahimi-Balaei M; Chen QM; Badbezanchi I; Shojaei S; Marzban A; Mirzaei N; Chung S; Guan T; Li J; Vriend J; Mehr SE; Kong J; Marzban H
Curr Mol Pharmacol; 2017; 10(2):115-140. PubMed ID: 26758948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]